Hereditary and Familial Colorectal Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 745
Special Issue Editors
Interests: gastrointestinal cancer; gastric cancer; colorectal cancer; lynch syndrome; pancreatic cancer
Special Issue Information
Dear Colleagues,
Hereditary and familial colorectal cancers represent nearly a quarter of all colorectal cancers diagnosed. This is caused by identifiable pathogenic germline variants in colorectal cancer risk genes, leading to known hereditary colorectal cancer risk syndromes such as Lynch syndrome or familial adenomatous polyposis (FAP), or may be also related to other familial factors that are less well defined. Identification of and germline genetic testing for these high-risk individuals and families is of paramount importance in terms of allowing for syndrome identification and risk stratification. Enhanced colorectal cancer and often extra-colonic cancer screening is important in terms of reduce morbidity and mortality in inidividuals with hereditary and familial colorectal cancer risk. Finally, cancer prevention through lifestyle modifications and chemoprevention may have a substantial impact on future cancer risk. This Special Issue of Cancers will be focused on hereditary and familial colorectal cancer, with a focus on identification of high-risk individuals and families, genetic testing, risk assessment, screening implementation and outcomes, and cancer prevention.
Dr. Bryson W. Katona
Dr. Peter P. Stanich
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hereditary colorectal cancer
- familial colorectal cancer
- genetic predisposition
- polyposis
- Lynch syndrome
- familial adenomatous polyposis (FAP)
- MUTYH-associated polyposis (MAP)
- genetic testing
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.